Cellares Raises $255M Series C to Launch First Integrated Development and Manufacturing Organization (IDMO) and Pioneering Smart Factory to Meet Global Demand for Life-Saving Cell Therapies

Series C is led by Koch Disruptive Technologies and includes Bristol Myers Squibb, DFJ Growth, Willett Advisors and existing investors Eclipse, Decheng Capital, and 8VC Cellares’ commercial-scale IDMO Smart Factory in Bridgewater, NJ is a 118,000 sq ft facility with capacity for 40,000…